Patents by Inventor Isabelle Bertholon

Isabelle Bertholon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INJECTABLE COMBINATION OF ADRENERGIC RECEPTOR AGONISTS WITH FILLERS, FOR DECREASING SKIN REACTIONS DUE TO INJECTION
    Publication number: 20150320743
    Abstract: The present invention concerns an injectable composition comprising a filler or a botulinum toxin and an adrenergic receptor agonist, and its use for diminishing, decreasing or avoiding skin reactions due to injection, specially redness, ecchymosis, bruising, bleeding, erythema, oedema, necrosis, ulceration, swelling and/or inflammation.
    Type: Application
    Filed: May 13, 2015
    Publication date: November 12, 2015
    Inventors: Isabelle Bertholon, Florence Brunel, Benjamin Herbage, Christophe Villard
  • Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
    Patent number: 9050246
    Abstract: The present invention concerns an injectable composition comprising a filler or a botulinum toxin and an adrenergic receptor agonist, and its use for diminishing, decreasing or avoiding skin reactions due to injection, specially redness, ecchymosis, bruising, bleeding, erythema, oedema, necrosis, ulceration, swelling and/or inflammation.
    Type: Grant
    Filed: May 28, 2010
    Date of Patent: June 9, 2015
    Assignee: Galderma Research & Development
    Inventors: Isabelle Bertholon, Florence Brunel, Benjamin Herbage, Sylviane Villard
  • INJECTABLE COMBINATION OF ADRENERGIC RECEPTOR AGONISTS WITH FILLERS, FOR DECREASING SKIN REACTIONS DUE TO INJECTION
    Publication number: 20120135937
    Abstract: The present invention concerns an injectable composition comprising a filler or a botulinum toxin and an adrenergic receptor agonist, and its use for diminishing, decreasing or avoiding skin reactions due to injection, specially redness, ecchymosis, bruising, bleeding, erythema, oedema, necrosis, ulceration, swelling and/or inflammation.
    Type: Application
    Filed: May 28, 2010
    Publication date: May 31, 2012
    Applicants: Galderma Research & Development, Symatese
    Inventors: Isabelle Bertholon, Florence Brunel, Benjamin Herbage, Christophe Villard, Sylviane Villard